Get the Daily Brief
Latest Biotech News
Tahoe Therapeutics Raises $30 Million to Build Billion-Cell AI Training Dataset
Tahoe Therapeutics secured $30 million in funding to contribute to the global effort of sequencing one billion cells. This initiative aims to create comprehensive virtual cell models to enhance...
Advances in Pediatric Cancer and Immunotherapy Biomarkers and Therapies
Researchers made strides in pediatric oncology and immunotherapy with several developments: A gene network and AI-driven study identified novel prognostic biomarkers in neuroblastoma, facilitating...
Biotech Industry Market Sentiment: Real Estate Slump and Funding Challenges in Boston
The Greater Boston life sciences sector is experiencing a significant oversupply crisis with 17 million square feet of available lab space and a vacancy rate near 30%, driven by speculative...
Vinay Prasad's Return to FDA’s CBER Amid Leadership Turmoil
Vinay Prasad was reinstated as director of the FDA's Center for Biologics Evaluation and Research (CBER) just two weeks after his removal, following a campaign that criticized his previous stances...
Emerging Technologies in Electron Tomography and Microscopy Enhance Material and Medical Research
Innovations in microscopy and electron tomography promise to accelerate research. A new rapid, automated multiscale electron tomography technique optimizes visualization of sensitive materials...
Cancer Center and Researchers Highlight Long-Term Health in Childhood Cancer Survivors
Collaborative research between The University of Texas at Arlington and City of Hope focuses on long-term health challenges faced by childhood cancer survivors, emphasizing the role wearable...
Novel Heat-Free Fruit Dehydration Technology Promises Sustainability in Food Preservation
Researchers have developed an innovative fruit dehydration method that operates at room temperature using controlled atmospheric pressure and food-safe calcium chloride, eliminating the...
Novartis Scores Double Phase 3 Wins in Sjögren’s Syndrome
Novartis has announced successful results from two Phase 3 trials of its antibody drug ianalumab in Sjögren’s syndrome, marking the first global studies demonstrating statistically significant...
IO Biotech’s Skin Cancer Vaccine Narrowly Misses Phase 3 Endpoint; FDA Path Planned
IO Biotech’s cancer vaccine Cylembio, tested in combination with Merck’s Keytruda for unresectable or metastatic melanoma, narrowly failed to meet its primary progression-free survival endpoint in...
Thermo Fisher Secures FDA Approval for Lung Cancer Companion Diagnostic
Thermo Fisher Scientific has obtained FDA approval for its Oncomine Dx Target Test as a companion diagnostic for Boehringer Ingelheim’s HERNEXEOS®, a tyrosine kinase inhibitor targeting...
Exact Sciences Buys Freenome’s Colorectal Cancer Blood Test Rights
Exact Sciences has acquired U.S. rights to Freenome’s colorectal cancer blood test for $75 million upfront, positioning itself against market rival Guardant Health in the liquid biopsy segment....
Canaccord Genuity Downgrades Quanterix Amid Integration Challenges
Investment bank Canaccord Genuity downgraded Quanterix shares from Buy to Hold, lowering the price target to $5 following disappointing Q2 2025 revenues and uncertainties in the integration of...
Nanotein and Sartorius Stedim Partner to Advance Cell Therapy Manufacturing
Sartorius Stedim Biotech has partnered with Nanotein Technologies, acquiring a minority stake to support commercialization and joint development of immune cell activation solutions based on...
Gut Microbiome Identified as Cause of Fibromyalgia-Like Pain in Mice
Researchers have demonstrated that fecal microbiome transplantation from fibromyalgia patients induces chronic pain symptoms in germ-free mice, establishing a causal role of gut microbes in...
Machine Learning Enhances Cardiovascular Diagnosis and Prognosis
Advances in machine learning have led to novel computational models that significantly improve prediction, diagnosis, and management of heart diseases such as stroke and myocardial infarction....
Neuroprosthetics Innovate Gut Motility and Metabolic Regulation
A novel gastrointestinal neuroprosthetic device has been developed to interface with the enteric nervous system, enabling precise neuromodulation of gut motility and metabolism. This bioelectronic...
Vinay Prasad Reinstated at FDA’s CBER After Abrupt Departure
Vinay Prasad has been reinstated as the director of the Center for Biologics Evaluation and Research (CBER) at the FDA, just weeks after his unexpected departure amid political controversy. The...
FDA Welcomes Back Vinay Prasad Amid Biotech Turmoil
Vinay Prasad has been reinstated as the director of the FDA's Center for Biologics Evaluation and Research (CBER) just weeks after his abrupt ouster, following internal controversy and political...
Novartis’ Ianalumab Wins Phase 3 Sjögren’s Trials
Novartis announced positive results from two pivotal Phase 3 clinical trials (Neptunus 1 and 2) demonstrating that its antibody drug ianalumab significantly reduced disease activity in patients...
Quanterix Downgraded Amid Integration and Market Weakness
Canaccord Genuity downgraded Quanterix’s stock from Buy to Hold, cutting its price target from $12 to $5 after the company's Q2 2025 revenues fell 29% year-over-year due to weak pharmaceutical and...